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INTRODUCTION 51
includes stromal cells and the immune system (Quail and Joyce 2013). In recent years there 68 has been a revolution in our understanding of the role that host factors, such as the immune 69 system, stroma and vasculature play in the process of cancer progression. This is evidenced by 70 the development of agents, such as checkpoint inhibitors, that provoke the immune system to 71 identify and eliminate cancer cells. Importantly, studies in mice have made a significant 72 contribution to these breakthroughs, such as with the clinically relevant PD-1 (Zago et al. 73 2016)and CTLA4 receptors (Leach et al. 1996) , which were first identified and functionally 74 characterised using mouse model systems. For this reason we sort to develop a genetic screen 75 to identify new genes as tumour cell extrinsic regulators of metastatic colonisation. 76
In designing our screen we aimed to, where possible, unbiasedly screen mouse mutants 77 to identify new genes involved in colonization of the lung, a common site of metastatic seeding 78 for many tumour types. To this end, we used the 'experimental metastasis assay', which we 79 have previously demonstrated is a sensitive, robust, and high-throughput method for in vivo 80 quantification of the ability of metastatic tumour cells to colonize a secondary organ (Speak et 81 al. 2017), to screen mutant mouse lines generated as part of the International Mouse 82
Phenotyping Consortium (Meehan et al. 2017) . In this paper we describe a collection of mutants 83 identified over 7 years of screening (1,300 mutant mouse lines). This study reveals previously 84 unappreciated pathways and processes that regulate this biology. Tail vein injection of mouse melanoma B16-F10 cells primarily results in pulmonary 145 colonisation (due to the capillary beds in the lungs being the first ones encountered by the cells 146 in the arterial blood after leaving the heart). As these cells are pigmented (melanin granules) 147 their colonisation of the lungs can be determined by macroscopic counting of the number of 148 black metastatic foci on the lungs (Figure 1A) . Sex-and age-matched wildtype mice were 149 concomitantly dosed with the cohorts of mutant mice (Figure 1B) , and the results from mutant 150 mice were only compared to the wildtype mice dosed at the same time (due to day-to-day 151 variations in the assay, and factors such as sex and age of the mice affecting metastatic burden 152 (Speak et al. 2017)). A 'metastatic ratio' (MR) was determined for each mutant mouse line, 153 which was calculated as the average number of metastatic colonies for the mutant line relative 154 to the average number of metastatic colonies for concomitantly dosed wildtype mice. If a mutant 155 mouse line showed a MR of <0.6 or >1.4 (and Mann-Whitney P<0.05), additional cohorts were 156 assayed (n≥2, assayed on independent days). An integrative data analysis (IDA) was performed 157 on the whole dataset and those with P<0.005 (Hochberg) and a biological effect ('genotype 158 effect') of ≤ -55 or ≥ +55 were classified as 'hits'. A biological filter was applied as we were only 159 interested in determining robust (strong) regulators of metastatic colonisation. 160
We used Entpd1 and Hsp90aa1 mutant mice as positive controls, as the literature 161 suggested they should show altered metastatic burden. Entpd1 (ectonucleoside triphosphate 162 diphosphohydrolase 1) encodes the plasma membrane protein CD39. The enzymatic activity of 163 CD39 (NTPDase I), together with CD73 (ecto-5'-nucleotidase), result in the phosphohydrolysis 164 of extracellular ATP into adenosine, which acts as an immunosuppressive pathway through the 165 activation of adenosine receptors (Stagg and Smyth 2010). Entpd1-deficient mice that were 166 administered B16-F10 mouse melanoma cells and MC-38 mouse colon cancer cells via the 167 hepatic portal vein (experimental metastasis assay) were found to develop significantly fewer 168 hepatic metastases than wildtype (control) mice (Sun et al. 2010). In agreement with this, we 169 found that Entpd1 mutant mice showed significantly reduced numbers of pulmonary metastatic 170 colonies after tail vein dosing with B16-F10 cells, relative to wildtype mice. Hsp90aa1 (heat 171 shock protein 90 alpha family class A member 1) encodes a molecular chaperone that functions prostate tumours, as well as the spread of metastatic prostate cancer to abdominal lymph nodes 177 and liver (Kang et al. 2011). In agreement with this, we found that Hsp90aa1 mutant mice 178 showed significantly reduced numbers of pulmonary metastatic colonies after tail vein dosing 179 with B16-F10 cells, relative to wildtype mice. Both Entpd1 and Hsp90aa1 were classified as 180 'hits' using the integrated data analysis (IDA) approach, thus we were confident that our 181 screening methodology was robust. 182
We have previously published the results of screening 810 mutant mouse lines and 183 showed that endothelial SPNS2 can regulate metastatic colonisation by sphingosine-1-184 phosphate (S1P)-mediated control of lymphocyte trafficking (van der Weyden et al. 2017a; van 185 der Weyden et al. 2017b). Here we have included an additional 490 mutant mouse lines, to 186 make a total of 1,300 mutant mouse lines (1,344 alleles) screened. The mutant mouse lines 187 were randomly selected and the genes (Table S1) cover a diverse range of molecular functions 188 (Figure 2a ) and are involved in many different biological processes (Figure 2b) . Of the 1,300 189 mutant muse lines screened, 1,247 lines (96%) carried alleles that targeted single protein 190 coding genes, with the other alleles targeting lncRNAs (21 lines), miRNAs (8 lines), CpG islands 191 (13 lines), pseudogenes (3 lines), complexes/clusters/regions (3 lines), multiple protein coding 192 genes (3 lines) or gene segments (2 lines). The raw data for each individual mouse (number of 193 metastases counted) is listed in Table S2 . The mutant mice tested were predominantly 194 homozygotes (880 lines, 68%), with heterozygotes generally only being tested (356 lines, 27%) 195 if the line was lethal or sub-viable (i.e., where 0 or ≤13% of homozygote offspring were obtained 196 from heterozygous intercrosses, respectively) and in a small number of cases both 197 heterozygotes and homozygotes were assessed (64 lines, 5%). An IDA was performed on the 198 data from the 256 mouse lines that showed evidence of a phenotype in initial screening and for 199 which at least 3 independent cohorts were tested, and the 34 mutant lines classified as 'hits' are 200
shown Table 1 . 201
202
DISCUSSION 203
204
We have characterised the mechanism of action for several genes that showed a 205 decreased metastatic colonisation phenotype in our screen, specifically Spns2 (van der Weyden of the 34 metastatic colonisation regulating genes detailed in this study show a strong 214 enrichment for genes involved in immune/haematopoietic system development and function with 215 phenotypes in those categories representing 88% of all the reported phenotypes associated 216 with those genes. 217
As we have previously predominantly focussed our attention genes positively regulating 218 metastatic colonisation (i.e., mutant mice showing decreased metastasis), we will now turn our 219 focus to discussing negative regulators of metastatic colonisation (i.e., mutant mice showing 220 increased metastasis). The Ring finger protein 10 (Rnf10) gene encodes a protein with a ring finger motif (a C3HC4-244 type zinc finger). Rnf10/RNF10 has been shown to be important for key neurobiology functions, adiposity and type 2 diabetes (Huang et al. 2014). We found that Rnf10-deficient mice showed 249 increased pulmonary metastatic colonisation, with males having a consistently higher metastatic 250 burden than females (290 ± 26 versus 153 ± 31, respectively); this is the only mutant line in 251 which we observed a sexually dimorphic effect. Further investigations are required to provide 252 mechanistic insight as to how Rnf10 may be regulating metastatic colonisation, and why it has a 253 stronger effect in males. Although much is known about these two genes and they have well established roles in 394 tumour cell-intrinsic roles in cancer, it is not clear at this stage how they may be mediating an 395 increased metastatic colonisation phenotype. 396 397 CONCLUSION 398
399
In summary, we have used the experimental metastasis assay to screen 1,300 mutant 400 mouse lines to identify novel host/microenvironmental regulators of metastatic colonisation. We 401 have identified 34 genes whose loss of expression results in either an increased or decreased 402 ability for mouse melanoma cells to undergo metastatic colonisation of the lung following tail 403 vein injection. Some of these genes regulate key pathways in immune cell development or 404 function, however many have only been shown to play a role in tumour cell-intrinsic pathways 405 with no known tumour cell-extrinsic functions reported, thus, we have identified numerous novel 406 regulators of pulmonary metastatic colonisation, which could represent potential therapeutic 407 targets. 408 409 410 Table S3 . 453 454   Table S3 . Explanation of how to interpret the data for the screen. An explanation of the 455 data format, data options and other relevant information to allow interpretation of the data in 456 Table S2 . 593 Table 1 . Results of the Integrative Data Analysis showing mutant mouse lines with statistically significant decreased or increased pulmonary metastatic colonisation (using a statistical threshold of P<0.0005 and a biological threshold of genotype estimate ≤ -55 or ≥ +55). The genotype of the mutant mice listed were all homozygotes except Id2, which were heterozygotes. 'Cohorts' was the number of individual cohorts that were tested for this particular mouse line. 'Genotype estimate' is the alteration in number of pulmonary metastatic colonies for that mutant mouse line relative to control mice. P value is the Hochberg test. * The mutant mice (and controls) were administered 1/10th dose of other lines. ** The genotype estimate is an average of the values obtained for both sexes (as there was a sex effect observed); the values for each sex are: 290 ± 26 (male) and 153 ± 31 (female). 
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